Alumni - Current Positions

If you are an alumnus and your information is not up to date, please contact Aileen Rosales at  (212) 746-6250 to provide us with your current information.   

(updated 06/2024)

Name Year of Graduation Advisor's Name Thesis Project Current Position
Juliana Xu 2004 Gudas, Lorraine Functional Studies of REX-1 Target Genes using F9 Teratocarcinoma Stem Cells as a Model System. Chief Technology Officer, Agria Corporation, NY
John Biggins 2003 Thorson, Jon The Mechanism of CalC - A Protein Conferring Self-Resistance to the Antitumor Antibiotic Calicheamicin within micromonospora echinospora ssp. calichensis Chemical Biologist, LifeMine Therapeutics- Biotechnology Drug Development, Cambridge, MA
Barbara Franklin (Gorfajn) 2003 Terminal Masters Update coming soon
Jack Liao 2003 Fisher, Robert PNQALRE, A Novel CDK Family Member, Associates with CDK-Activating Kinase (CAK) in vivo, and is Required for Normal Proliferation of Mammalian Cells in Culture. Postdoctoral Fellow, The Donaldson-Atwood Cancer Clinic, The Animal Medical Center
Tatiana Litvin 2003 Buck, Jochen A Novel Mechanism of Adenylyl Cylcase Activation Conserved from Cyanobacteria to Man Assistant Director, Office of Patents and Licensing, UMDNJ
Pellegrino Magro 2003 Bertino, Joseph The Effect of p14ARF on DHFR and its Implications on Antifolate Drug Sensitivity. Scientific Director, MedLearning, Inc.
Angelo Russo 2003 Bertino, Joseph Examination of the Role of E2F-1 in the Cellular Response to Antimitotic Agents Associate Medical Director/Medical Writer, Lowe Healthcare Company, Integrated Communications
Andrea D. Basso 2002 Rosen, Neal Regulation of Akt Expression and Signaling by the Hsp90 Chaperone. Associate Principal Scientist, Schering-Plough Research Institute
Elizabeth Bolan 2002 Scotto, Kathleen Molecular and Pharmacological Characterization of Mu Opioid Receptor Hetergeneity. Pharmacologist, FDA
Gina Capiaux 2002 Bertino, Joseph A Fusion Protein of Mutant Dihydrofolate Reductase and Mutant Thymidylate Synthase for Conferring Myeloprotection against Methotrexate and 5-Fluorouracil: Characterization and in vivo Analysis. Sr. Director, Ultragenyx Pharmaceuticals Inc.
Francesca Domenech (Wuttke) 2002 Laurence, Jaffrey Inhibition of SDF1 - Mediated Megakaryocyte Migration by HIV gp120: A New Mechanism for HIV - Associated Thrombocytopenia. Founder and Principal, Asten BioPharma Advisors, LLC, New York, NY
Debbie Friedman 2002 Scotto, Kathleen Transcriptional Regulation by Sp1 Family Members.
Paul Moench 2002 Terminal Masters Bristol Myers Squibb Oncology Research
Wendy Roberts 2002 Scheinberg, David Vaccination Against Normal and Neoplastic B Cells with CD20 Peptides Research Associate, The Rockefeller University, New York, NY
Haijuan Yang 2002 Pavlevitch, Nikola Novel Function Unveiled by the Crystal Structure of the BRCA2 Tumor Suppressor. Research Fellow, Pavlevitch Laboratory, Memorial Sloan-Kettering Cancer Center